567 related articles for article (PubMed ID: 32988222)
21. Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review).
Chong S; Mu G; Cen X; Xiang Q; Cui Y
Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38757360
[TBL] [Abstract][Full Text] [Related]
22. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
[TBL] [Abstract][Full Text] [Related]
23. XJ-8, a natural compound isolated from Sanguis draxonis, inhibits platelet function and thrombosis by targeting MAP3K3.
Zhu Z; Wang L; Guo R; Pang D; Wang W; Wu Y; Wei N; Li J; Tu P
J Thromb Haemost; 2022 Mar; 20(3):605-618. PubMed ID: 34780114
[TBL] [Abstract][Full Text] [Related]
24. [Effect of proprotein convertase subtilisin/kexin type 9 on platelet activation associated with sepsis].
Gao Y; Wang J; Huang X; Xu J; Li J; Sun D; Hao D; Ning F; Wang X; Wang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):807-812. PubMed ID: 37593857
[TBL] [Abstract][Full Text] [Related]
25. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.
Ding Z; Liu S; Wang X; Theus S; Deng X; Fan Y; Zhou S; Mehta JL
Cardiovasc Res; 2018 Jul; 114(8):1145-1153. PubMed ID: 29617722
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q
J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100
[TBL] [Abstract][Full Text] [Related]
27. Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in Apc
Yang K; Zhu J; Luo HH; Yu SW; Wang L
Int J Immunopathol Pharmacol; 2021; 35():20587384211038345. PubMed ID: 34586888
[TBL] [Abstract][Full Text] [Related]
28. Ask1 regulates murine platelet granule secretion, thromboxane A
Naik MU; Patel P; Derstine R; Turaga R; Chen X; Golla K; Neeves KB; Ichijo H; Naik UP
Blood; 2017 Mar; 129(9):1197-1209. PubMed ID: 28028021
[TBL] [Abstract][Full Text] [Related]
29. The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes.
Fazaeli M; Khoshdel A; Shafiepour M; Rohban M
Diabetes Metab Syndr; 2019; 13(1):312-316. PubMed ID: 30641718
[TBL] [Abstract][Full Text] [Related]
30. Platelet Extracellular Regulated Protein Kinase 5 Is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion.
Cameron SJ; Ture SK; Mickelsen D; Chakrabarti E; Modjeski KL; McNitt S; Seaberry M; Field DJ; Le NT; Abe J; Morrell CN
Circulation; 2015 Jul; 132(1):47-58. PubMed ID: 25934838
[TBL] [Abstract][Full Text] [Related]
31. Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease.
Petersen-Uribe Á; Kremser M; Rohlfing AK; Castor T; Kolb K; Dicenta V; Emschermann F; Li B; Borst O; Rath D; Müller KAL; Gawaz MP
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681838
[TBL] [Abstract][Full Text] [Related]
32. A review of PCSK9 inhibition and its effects beyond LDL receptors.
Dixon DL; Trankle C; Buckley L; Parod E; Carbone S; Van Tassell BW; Abbate A
J Clin Lipidol; 2016; 10(5):1073-80. PubMed ID: 27678423
[TBL] [Abstract][Full Text] [Related]
33. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
[TBL] [Abstract][Full Text] [Related]
34. Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.
Zimman A; Titz B; Komisopoulou E; Biswas S; Graeber TG; Podrez EA
PLoS One; 2014; 9(1):e84488. PubMed ID: 24400094
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic effects of proprotein convertase subtilisin/kexin type 9 inhibitors?
Filippatos TD; Christopoulou EC; Elisaf MS
Curr Opin Lipidol; 2018 Aug; 29(4):333-339. PubMed ID: 29994840
[TBL] [Abstract][Full Text] [Related]
36. Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis.
Cammisotto V; Baratta F; Simeone PG; Barale C; Lupia E; Galardo G; Santilli F; Russo I; Pignatelli P
Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326219
[TBL] [Abstract][Full Text] [Related]
37. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
[TBL] [Abstract][Full Text] [Related]
38. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.
Weider E; Susan-Resiga D; Essalmani R; Hamelin J; Asselin MC; Nimesh S; Ashraf Y; Wycoff KL; Zhang J; Prat A; Seidah NG
J Biol Chem; 2016 Aug; 291(32):16659-71. PubMed ID: 27284008
[TBL] [Abstract][Full Text] [Related]
39. PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation.
Cammisotto V; Pastori D; Nocella C; Bartimoccia S; Castellani V; Marchese C; Scavalli AS; Ettorre E; Viceconte N; Violi F; Pignatelli P; Carnevale R
Antioxidants (Basel); 2020 Apr; 9(4):. PubMed ID: 32252393
[TBL] [Abstract][Full Text] [Related]
40. Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
Liu J; Pestina TI; Berndt MC; Jackson CW; Gartner TK
Blood; 2005 Oct; 106(8):2750-6. PubMed ID: 15985541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
